Two-drug combo shows durable benefit in advanced kidney cancer
A two-drug combination for treating advanced kidney cancer had sustained and durable clinical benefit in more than five years of follow-up, according to a study published Aug. 1 in Nature Medicine.
https://www.news-medical.net/n....ews/20250801/Two-dru
Discover the world at Altruu, The Discovery Engine